Cytomx Therapeutics, Inc. · NASDAQ:CTMX

FMR LLC reported a 5.90% stake in Cytomx Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 6, 2025

FMR LLC reported a 5.90% stake in Cytomx Therapeutics, Inc., 9,238,868 shares, as a passive investor on Jun 30, 2025. Filed Aug 6, 2025 (Schedule 13G).

Stake
5.90%
Shares
9,238,868
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
FMR LLC5.90%9,238,868
Abigail P. Johnson5.90%9,238,868

Source

View original at SEC

Related